Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Partnership for Research on Ebola VACcinations (PREVAC)

Next Previous
Trial Profile

Partnership for Research on Ebola VACcinations (PREVAC)

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Nov 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ad26 EBOV vaccine (Primary) ; Modified Vaccinia Ankara Bavarian Nordic Ebola Marburg vaccine (Primary) ; RVSV-S-GP/VP40 vaccine (Primary)
  • Indications Ebola virus infections
  • Focus Pharmacodynamics
  • Acronyms PREVAC

    • Most Recent Events

    • 15 Nov 2023 Results accessing immunogenicity and vaccine shedding after 1 or 2 doses of Ebola vaccine in prevention of Ebola-virus-infections, published in the Clinical Infectious Diseases.
    • 14 Dec 2022 Results evaluating the safety and immune responses of three vaccine regimens against Zaire Ebola virus disease, published in the New England Journal of Medicine
    • 27 Jul 2020 Planned primary completion date changed from 1 May 2020 to 31 Jan 2021.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top